Cargando…
PKCδ promotes the invasion and migration of colorectal cancer through c-myc/NDRG1 pathway
OBJECTIVE: Colorectal cancer (CRC) is the third cause of expected cancer deaths both in men and women in the U.S. and the third most commonly diagnosed cancer in China Targeted therapy has been proven to improve overall survival for unresectable metastatic CRC. But the location of the primary tumor...
Autores principales: | Jia, Hong-tao, Shao, Yan-fei, Zhou, Xue-liang, Yang, Guang, Huang, Ling, Aikemu, Batuer, Li, Shu-chun, Ding, Cheng-sheng, Fan, Xiao-dong, Hong, Hi-ju, Zhang, Sen, Pan, Rui-jun, Sun, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9933346/ https://www.ncbi.nlm.nih.gov/pubmed/36816970 http://dx.doi.org/10.3389/fonc.2023.1026561 |
Ejemplares similares
-
NDRG1 regulates Filopodia-induced Colorectal Cancer invasiveness via modulating CDC42 activity
por: Aikemu, Batuer, et al.
Publicado: (2021) -
NDRG1 enhances the sensitivity of cetuximab by modulating EGFR trafficking in colorectal cancer
por: Yang, Guang, et al.
Publicado: (2021) -
An Original Ferroptosis-Related Gene Signature Effectively Predicts the Prognosis and Clinical Status for Colorectal Cancer Patients
por: Shao, Yanfei, et al.
Publicado: (2021) -
Kaempferol exhibits a synergistic effect with doxorubicin to inhibit proliferation, migration, and invasion of liver cancer
por: Yang, Guang, et al.
Publicado: (2021) -
ACACB is a novel metabolism-related biomarker in the prediction of response to cetuximab therapy inmetastatic colorectal cancer: ACACB is a biomarker for CTX therapy in metastatic CRC
por: Hong, Hi-Ju, et al.
Publicado: (2022)